BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31085136)

  • 1. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.
    Kotzerke D; Moritz F; Mantovani L; Hambsch P; Hering K; Kuhnt T; Yahiaoui-Doktor M; Forstmeyer D; Lordick F; Knödler M
    J Geriatr Oncol; 2019 Nov; 10(6):937-943. PubMed ID: 31085136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.
    Chan WL; Ma T; Cheung KL; Choi H; Wong J; Lam KO; Yuen KK; Luk MY; Kwong D
    J Geriatr Oncol; 2021 May; 12(4):557-562. PubMed ID: 33127385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.
    AlSendi M; Flynn CR; Khan MR; Selvadurai P; Crown J; McDermott RS; Walshe JM; Fennelly DW; Hanrahan EO; Doherty M; Higgins MJ
    Ir J Med Sci; 2024 Feb; 193(1):45-50. PubMed ID: 37450258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the G8 screening tool in older patients with aggressive haematological malignancies.
    Velghe A; Petrovic M; De Buyser S; Demuynck R; Noens L
    Eur J Oncol Nurs; 2014 Dec; 18(6):645-8. PubMed ID: 24954768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
    Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
    J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.
    Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
    J Geriatr Oncol; 2014 Apr; 5(2):179-84. PubMed ID: 24495700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
    Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
    J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies.
    Cavusoglu C; Tahtaci G; Dogrul RT; Ileri I; Yildirim F; Candemir B; Kizilarslanoglu MC; Uner A; Goker B
    BMC Geriatr; 2021 Oct; 21(1):574. PubMed ID: 34666690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.
    Mariano C; Jamal R; Bains P; Hejazi S; Chao L; Wan J; Ho J
    Curr Oncol; 2019 Aug; 26(4):234-239. PubMed ID: 31548802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of G8 for functional decline.
    Chakiba C; Bellera C; Etchepare F; Mathoulin-Pelissier S; Rainfray M; Soubeyran P
    J Geriatr Oncol; 2019 Nov; 10(6):921-925. PubMed ID: 30638869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.
    Dottorini L; Catena L; Sarno I; Di Menna G; Marte A; Novelli E; Rusca C; Bajetta E
    J Geriatr Oncol; 2019 Mar; 10(2):356-358. PubMed ID: 30333087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):210-215. PubMed ID: 30503312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients.
    Penning Y; El Asmar A; Moreau M; Raspé J; Dal Lago L; Pepersack T; Donckier V; Liberale G
    PLoS One; 2022; 17(3):e0264790. PubMed ID: 35239731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.
    Neve M; Jameson MB; Govender S; Hartopeanu C
    J Geriatr Oncol; 2016 Nov; 7(6):457-462. PubMed ID: 27313080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer.
    Yokom DW; Alibhai SMH; Sattar S; Krzyzanowska MK; Puts MTE
    J Geriatr Oncol; 2018 Nov; 9(6):683-686. PubMed ID: 29540293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of two geriatric screening tools in older patients with cancer.
    Kenis C; Decoster L; Van Puyvelde K; De Grève J; Conings G; Milisen K; Flamaing J; Lobelle JP; Wildiers H
    J Clin Oncol; 2014 Jan; 32(1):19-26. PubMed ID: 24276775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer.
    Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
    J Geriatr Oncol; 2013 Jan; 4(1):32-8. PubMed ID: 24071490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.